Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer.

Vuk-Pavlović S, Bulur PA, Lin Y, Qin R, Szumlanski CL, Zhao X, Dietz AB.

Prostate. 2010 Mar 1;70(4):443-55. doi: 10.1002/pros.21078.

2.

Thiopurine methyltransferase activity in red blood cells of dogs.

Kidd LB, Salavaggione OE, Szumlanski CL, Miller JL, Weinshilboum RM, Trepanier L.

J Vet Intern Med. 2004 Mar-Apr;18(2):214-8.

3.

Intensification of mercaptopurine/methotrexate maintenance chemotherapy may increase the risk of relapse for some children with acute lymphoblastic leukemia.

Schmiegelow K, Björk O, Glomstein A, Gustafsson G, Keiding N, Kristinsson J, Mäkipernaa A, Rosthøj S, Szumlanski C, Sørensen TM, Weinshilboum R.

J Clin Oncol. 2003 Apr 1;21(7):1332-9.

PMID:
12663723
4.

Canine red blood cell thiopurine S-methyltransferase: companion animal pharmacogenetics.

Salavaggione OE, Kidd L, Prondzinski JL, Szumlanski CL, Pankratz VS, Wang L, Trepanier L, Weinshilboum RM.

Pharmacogenetics. 2002 Dec;12(9):713-24.

PMID:
12464800
5.

Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide.

Lowry PW, Franklin CL, Weaver AL, Szumlanski CL, Mays DC, Loftus EV, Tremaine WJ, Lipsky JJ, Weinshilboum RM, Sandborn WJ.

Gut. 2001 Nov;49(5):656-64.

6.

Severe 6-thioguanine-induced marrow aplasia in a child with acute lymphoblastic leukemia and inherited thiopurine methyltransferase deficiency.

McBride KL, Gilchrist GS, Smithson WA, Weinshilboum RM, Szumlanski CL.

J Pediatr Hematol Oncol. 2000 Sep-Oct;22(5):441-5.

PMID:
11037857
7.

Thiopurine methyltransferase polymorphic tandem repeat: genotype-phenotype correlation analysis.

Yan L, Zhang S, Eiff B, Szumlanski CL, Powers M, O'Brien JF, Weinshilboum RM.

Clin Pharmacol Ther. 2000 Aug;68(2):210-9.

PMID:
10976552
8.

Histamine N-methyltransferase functional polymorphism: lack of association with schizophrenia.

Yan L, Szumlanski CL, Rice SR, Sobell JL, Lachman HM, Weinshilboum RM.

Am J Med Genet. 2000 Jun 12;96(3):404-6.

PMID:
10898922
9.

The relationship between COMT genotype and the clinical effectiveness of tolcapone, a COMT inhibitor, in patients with Parkinson's disease.

Chong DJ, Suchowersky O, Szumlanski C, Weinshilboum RM, Brant R, Campbell NR.

Clin Neuropharmacol. 2000 May-Jun;23(3):143-8.

PMID:
10895397
10.

Possible carcinogenic effect of 6-mercaptopurine on bone marrow stem cells: relation to thiopurine metabolism.

Bo J, Schrøder H, Kristinsson J, Madsen B, Szumlanski C, Weinshilboum R, Andersen JB, Schmiegelow K.

Cancer. 1999 Sep 15;86(6):1080-6.

PMID:
10491537
11.

Balsalazide and azathiprine or 6-mercaptopurine: evidence for a potentially serious drug interaction.

Lowry PW, Szumlanski CL, Weinshilboum RM, Sandborn WJ.

Gastroenterology. 1999 Jun;116(6):1505-6. No abstract available.

PMID:
10391741
12.

Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase.

Weinshilboum RM, Otterness DM, Szumlanski CL.

Annu Rev Pharmacol Toxicol. 1999;39:19-52. Review.

PMID:
10331075
13.

Human histamine N-methyltransferase pharmacogenetics: common genetic polymorphisms that alter activity.

Preuss CV, Wood TC, Szumlanski CL, Raftogianis RB, Otterness DM, Girard B, Scott MC, Weinshilboum RM.

Mol Pharmacol. 1998 Apr;53(4):708-17.

14.
15.

Pharmacokinetics, dose adjustments, and 6-mercaptopurine/methotrexate drug interactions in two patients with thiopurine methyltransferase deficiency.

Andersen JB, Szumlanski C, Weinshilboum RM, Schmiegelow K.

Acta Paediatr. 1998 Jan;87(1):108-11.

PMID:
9510461
16.

Olsalazine and 6-mercaptopurine-related bone marrow suppression: a possible drug-drug interaction.

Lewis LD, Benin A, Szumlanski CL, Otterness DM, Lennard L, Weinshilboum RM, Nierenberg DW.

Clin Pharmacol Ther. 1997 Oct;62(4):464-75. Erratum in: Clin Pharmacol Ther 2000 Apr;67(4):431.

PMID:
9357398
17.

Human erythrocyte protein L-isoaspartyl methyltransferase: heritability of basal activity and genetic polymorphism for thermal stability.

David CL, Szumlanski CL, DeVry CG, Park-Hah JO, Clarke S, Weinshilboum RM, Aswad DW.

Arch Biochem Biophys. 1997 Oct 15;346(2):277-86.

PMID:
9343375
18.

Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms.

Otterness D, Szumlanski C, Lennard L, Klemetsdal B, Aarbakke J, Park-Hah JO, Iven H, Schmiegelow K, Branum E, O'Brien J, Weinshilboum R.

Clin Pharmacol Ther. 1997 Jul;62(1):60-73.

PMID:
9246020
19.

Human jejunal estrogen sulfotransferase and dehydroepiandrosterone sulfotransferase: immunochemical characterization of individual variation.

Her C, Szumlanski C, Aksoy IA, Weinshilboum RM.

Drug Metab Dispos. 1996 Dec;24(12):1328-35.

PMID:
8971138
20.

Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders.

Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM.

Pharmacogenetics. 1996 Jun;6(3):243-50.

PMID:
8807664
21.

Mouse liver nicotinamide N-methyltransferase pharmacogenetics: biochemical properties and variation in activity among inbred strains.

Scheller T, Orgacka H, Szumlanski CL, Weinshilboum RM.

Pharmacogenetics. 1996 Feb;6(1):43-53.

PMID:
8845860
22.

Thiopurine methyltransferase pharmacogenetics: human gene cloning and characterization of a common polymorphism.

Szumlanski C, Otterness D, Her C, Lee D, Brandriff B, Kelsell D, Spurr N, Lennard L, Wieben E, Weinshilboum R.

DNA Cell Biol. 1996 Jan;15(1):17-30.

PMID:
8561894
23.

Toxicity and metabolism in mice of 2,6-dithiopurine, a potential chemopreventive agent.

Qing WG, Powell KL, Stoica G, Szumlanski CL, Weinshilboum RM, Macleod MC.

Drug Metab Dispos. 1995 Aug;23(8):854-60.

PMID:
7493553
24.
25.

Thiopurine methyltransferase pharmacogenetics. Cloning of human liver cDNA and a processed pseudogene on human chromosome 18q21.1.

Lee D, Szumlanski C, Houtman J, Honchel R, Rojas K, Overhauser J, Wieben ED, Weinshilboum RM.

Drug Metab Dispos. 1995 Mar;23(3):398-405.

PMID:
7628307
26.

Purine substrates for human thiopurine methyltransferase.

Deininger M, Szumlanski CL, Otterness DM, Van Loon J, Ferber W, Weinshilboum RM.

Biochem Pharmacol. 1994 Nov 29;48(11):2135-8.

PMID:
7802704
27.

Human liver nicotinamide N-methyltransferase. cDNA cloning, expression, and biochemical characterization.

Aksoy S, Szumlanski CL, Weinshilboum RM.

J Biol Chem. 1994 May 20;269(20):14835-40.

28.

Human thiopurine methyltransferase: molecular cloning and expression of T84 colon carcinoma cell cDNA.

Honchel R, Aksoy IA, Szumlanski C, Wood TC, Otterness DM, Wieben ED, Weinshilboum RM.

Mol Pharmacol. 1993 Jun;43(6):878-87.

PMID:
8316220
29.

Human kidney thiopurine methyltransferase. Photoaffinity labeling with S-adenosyl-L-methionine.

Van Loon JA, Szumlanski CL, Weinshilboum RM.

Biochem Pharmacol. 1992 Aug 18;44(4):775-85.

PMID:
1510725
30.

Human liver thiopurine methyltransferase pharmacogenetics: biochemical properties, liver-erythrocyte correlation and presence of isozymes.

Szumlanski CL, Honchel R, Scott MC, Weinshilboum RM.

Pharmacogenetics. 1992 Aug;2(4):148-59.

PMID:
1306116
31.

Electrophoretic analysis of low and high activity forms of catechol-O-methyltransferase in human erythrocytes.

Grossman MH, Szumlanski C, Littrell JB, Weinstein R, Weinshilboum RM.

Life Sci. 1992;50(7):473-80.

PMID:
1542252
32.

Human liver xanthine oxidase: nature and extent of individual variation.

Guerciolini R, Szumlanski C, Weinshilboum RM.

Clin Pharmacol Ther. 1991 Dec;50(6):663-72.

PMID:
1752110
33.

Mouse kidney histamine N-methyltransferase: assay conditions, biochemical properties and strain variation.

Scott MC, Guerciolini R, Szumlanski C, Weinshilboum RM.

Agents Actions. 1991 Mar;32(3-4):194-202.

PMID:
1907425
34.

Human liver catechol-O-methyltransferase pharmacogenetics.

Boudíková B, Szumlanski C, Maidak B, Weinshilboum R.

Clin Pharmacol Ther. 1990 Oct;48(4):381-9.

PMID:
2225698
35.

Human liver nicotinamide N-methyltransferase: ion-pairing radiochemical assay, biochemical properties and individual variation.

Rini J, Szumlanski C, Guerciolini R, Weinshilboum RM.

Clin Chim Acta. 1990 Jan 31;186(3):359-74.

PMID:
2311261
36.

Human intestinal phenol sulfotransferase: assay conditions, activity levels and partial purification of the thermolabile form.

Sundaram RS, Szumlanski C, Otterness D, van Loon JA, Weinshilboum RM.

Drug Metab Dispos. 1989 May-Jun;17(3):255-64.

PMID:
2568905
37.

Foreign compound metabolism studies with human liver obtained as surgical waste. Relation to donor characteristics and effects of tissue storage.

Powis G, Jardine I, Van Dyke R, Weinshilboum R, Moore D, Wilke T, Rhodes W, Nelson R, Benson L, Szumlanski C.

Drug Metab Dispos. 1988 Jul-Aug;16(4):582-9.

PMID:
2903027

Supplemental Content

Loading ...
Support Center